Primary Job Title President & CEO Primary Organization 
Sanovas
Location San Francisco Bay Area, California, United States Regions West Coast, Western US Gender Male Also Known As Lawrence Gerrans, Lawrence J. Gerrans
LinkedIn View on LinkedIn
Larry Gerrans began his medical device career as a Total Joint Replacement Specialist for Depuy Orthopedics (Johnson & Johnson), where he worked with many of the world's premier orthopedic surgeons in the education and intra-operative consultation of primary and revision total joint arthroplasty. Gerrans became a recognized expert in the
training and consultation of mobile bearing knee arthroplasty and was a clinical development specialist in the launch of various total joint arthroplasty and spine reconstruction systems. During his tenure Gerrans grew his business unit to $25M in four years and secured Depuy's very first National HMO Contract with Kaiser Permanente.
As minimally invasive surgery (MIS) became prevalent in the 1990's Mr. Gerrans played an active role in the innovation and deployment of MIS techniques, devices and implants for the burgeoning endoscopic market; to include surgical technologies and protocol for the general surgery, gynecology, urology, cardio-thoracic, neuro-surgery, ENT and orthopedic /sports medicine sectors. Accordingly, he participated in a number of technology development initiatives, becoming adept at forging 'Innovation Teams' comprised of surgeons, engineers, regulatory, manufacturing, clinical education, marketing and sales; bringing hundreds of products from concept to commercialization.
Gerrans' team was among the first medical industry personnel to enter the Los Alamos National Laboratory to evaluate various technologies for transfer to private industry. The most recognizable being the solution to the Oxy-Hydro combustion equation; relating to the use of radiofrequency ablation technology for soft tissue modification in orthopedic sports medicine.
Gerrans pioneered the Endo-Suite and Digital Operating Room technologies for Stryker and Smith & Nephew, respectively, and architected one of the first electronic operative notes systems; leading to the rise of electronic medical records. He led the clinical development and sales of the medical industry's first voice-activation technology for surgical device control in the operating theatre-the Hermes Voice Activation and Surgical Device Control System. His technology development and acquisition initiatives grew this new technology sector into a multi-national, multi-billion dollar healthcare construction enterprise that has re-invented operating rooms worldwide.
As co-founder of Sanovas, Mr. Gerrans is currently leading the next generation of interventional pulmonary science. Mr. Gerrans serves on the advisory board for the Advanced Medical Technology Association's (AdvaMed) Emerging Growth Companies Council, which provides a forum for promoting the interests of AdvaMed's emerging companies. AdvaMed is the world's largest medical technology association, representing more than 1,200 developers and manufacturers of medical devices, diagnostic products and medical information systems. He is also an advisory board member for Frost & Sullivan's 2013 Medical Device Program.
His personal initiative in technology, business development and national contracting works on behalf of Smith & Nephew culminated in Smith & Nephew being awarded an $80M national sole-source contract with Kaiser Permanente Medical Group for the development and construction of over 250 Digital Operating Rooms as well as a $15M contract award for sports medicine devices and implants. Mr. Gerrans has gained extensive organizational development and P&L experience; working for Depuy (J&J), Stryker, Smith & Nephew and Halo Management Group. He has advanced through sales to positions of key market specialist, director of business development, director of sales, vice president and general manager.
